Location: Boston, MA
CIK: 0001583977 · Show all filings
Period: Q1 2022 (← Previous) (Next →)
Filing Date: May 16, 2022
Total Value: $1.302B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | TURNING POINT THERAPEUTICS I | 3,700,000 | $99.34M | 7.6% | $45.88 | — | COM | 90041T108 |
| ERAS | ERASCA INC | 10,505,554 | $90.35M | 6.9% | $20.63 | -43.8% | COM | 29479A108 |
| DSGN | DESIGN THERAPEUTICS INC | 5,156,994 | $83.28M | 6.4% | $30.63 | -50.0% | COM | 25056L103 |
| — | PROMETHEUS BIOSCIENCES INC | 1,823,444 | $68.85M | 5.3% | $17.46 | — | COM | 74349U108 |
| — | GREENLIGHT BIOSCIENCS HLDS P | 6,710,540 | $62.04M | 4.8% | $9.24 | — | COMMON STOCK | 39536G105 |
| APLS | APELLIS PHARMACEUTICALS INC | 1,125,000 | $57.16M | 4.4% | $30.07 | +46.8% | COM | 03753U106 |
| RVMD | REVOLUTION MEDICINES INC | 1,995,066 | $50.89M | 3.9% | $29.60 | -26.5% | COM | 76155X100 |
| EWTX | EDGEWISE THERAPEUTICS INC | 4,682,874 | $45.42M | 3.5% | $25.59 | -49.7% | COM | 28036F105 |
| GLUE | MONTE ROSA THERAPEUTICS INC | 3,002,199 | $42.09M | 3.2% | $20.37 | -31.8% | COM | 61225M102 |
| — | FORMA THERAPEUTICS HLDGS INC | 4,068,351 | $37.84M | 2.9% | $41.85 | — | SHS | 34633R104 |
| RNAM | AVIDITY BIOSCIENCES INC | 2,012,115 | $37.16M | 2.9% | $28.83 | -41.1% | COM | 05370A108 |
| TNGX | TANGO THERAPEUTICS INC | 4,899,185 | $37.14M | 2.9% | $11.99 | -27.7% | COM | 87583X109 |
| — | AEROVATE THERAPEUTICS INC | 1,830,691 | $33.56M | 2.6% | $21.97 | — | COM | 008064107 |
| MLTX | HELIX ACQUISITION CORP | 3,280,000 | $33.27M | 2.6% | $10.26 | — | COM CL A | G4444C102 |
| TARS | TARSUS PHARMACEUTICALS INC | 1,375,982 | $23.14M | 1.8% | $28.48 | -34.9% | COM | 87650L103 |
| STOK | STOKE THERAPEUTICS INC | 1,087,807 | $22.9M | 1.8% | $26.85 | -25.4% | COM | 86150R107 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 2,489,894 | $22.33M | 1.7% | $17.92 | — | SPONSORED ADS | 152309100 |
| — | CHEMOCENTRYX INC | 865,000 | $21.69M | 1.7% | $30.31 | — | COM | 16383L106 |
| — | AXONICS INC | 322,240 | $20.17M | 1.5% | $15.11 | — | COM | 05465P101 |
| — | KARUNA THERAPEUTICS INC | 150,000 | $19.02M | 1.5% | $126.79 | — | COM | 48576A100 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 1,000,000 | $18.49M | 1.4% | $19.07 | +0.8% | COM | 92790C104 |
| — | VERVE THERAPEUTICS INC | 700,710 | $15.99M | 1.2% | $49.89 | — | COM | 92539P101 |
| BBIO | BRIDGEBIO PHARMA INC | 1,568,909 | $15.92M | 1.2% | $27.82 | -63.1% | COM | 10806X102 |
| — | ADICET BIO INC | 750,000 | $14.98M | 1.1% | $17.49 | — | COM | 007002108 |
| IMRX | IMMUNEERING CORP | 2,302,626 | $14.9M | 1.1% | $26.82 | -64.2% | CLASS A COM | 45254E107 |
| CYTK | CYTOKINETICS INC | 400,000 | $14.72M | 1.1% | $29.44 | +20.7% | COM NEW | 23282W605 |
| BMEA | BIOMEA FUSION INC | 3,170,872 | $14.14M | 1.1% | $17.65 | -63.3% | COM | 09077A106 |
| RCKT | ROCKET PHARMACEUTICALS INC | 868,550 | $13.78M | 1.1% | $16.47 | +4.9% | COM | 77313F106 |
| PHVS | PHARVARIS N V | 684,888 | $12.42M | 1.0% | $31.46 | -44.1% | COM | N69605108 |
| — | LONGBOARD PHARMACEUTICALS IN | 2,273,221 | $12.14M | 0.9% | $15.79 | — | COM | 54300N103 |
| ALXO | ALX ONCOLOGY HLDGS INC | 712,079 | $12.03M | 0.9% | $42.62 | -59.9% | COM | 00166B105 |
| — | RAIN THERAPEUTICS INC | 2,326,660 | $11.8M | 0.9% | $15.13 | — | COM | 75082Q105 |
| — | TALARIS THERAPEUTICS INC | 1,174,723 | $11.56M | 0.9% | $14.20 | — | COM | 87410C104 |
| AVIR | ATEA PHARMACEUTICALS INC | 1,547,181 | $11.17M | 0.9% | $32.23 | -78.9% | COM | 04683R106 |
| GHRS | GH RESEARCH PLC | 608,123 | $11.12M | 0.9% | $20.43 | -13.5% | ORDINARY SHARES | G3855L106 |
| — | IGM BIOSCIENCES INC | 402,200 | $10.75M | 0.8% | $57.43 | — | COM | 449585108 |
| VTYX | VENTYX BIOSCIENCES INC | 785,303 | $10.66M | 0.8% | $18.95 | -29.5% | COM | 92332V107 |
| — | HORIZON THERAPEUTICS PUB L | 100,000 | $10.52M | 0.8% | $105.21 | — | SHS | G46188101 |
| — | AMBRX BIOPHARMA INC | 2,486,386 | $10.24M | 0.8% | $18.92 | — | SPONSORED ADS | 02290A102 |
| BCAB | BIOATLA INC | 2,038,215 | $10.19M | 0.8% | $29.04 | -71.2% | COM | 09077B104 |
| — | VECTIVBIO HLDG AG | 2,078,485 | $9.79M | 0.8% | $11.47 | — | ORD SHS | H9060V101 |
| — | BIOHAVEN PHARMACTL HLDG CO L | 80,000 | $9.486M | 0.7% | $118.58 | — | COM | G11196105 |
| — | INTRA CELLULAR THERAPIES INC | 150,000 | $9.178M | 0.7% | $61.19 | — | COM | 46116X101 |
| OLMA | OLEMA PHARMACEUTICALS INC | 2,082,000 | $8.869M | 0.7% | $46.89 | -88.2% | COM | 68062P106 |
| TYRA | TYRA BIOSCIENCES INC | 757,432 | $8.105M | 0.6% | $19.11 | -37.9% | COM | 90240B106 |
| — | PRAXIS PRECISION MEDICINES I | 752,406 | $7.682M | 0.6% | $53.75 | — | COM | 74006W108 |
| ASND | ASCENDIS PHARMA A/S | 50,000 | $5.868M | 0.5% | $124.16 | — | SPONSORED ADR | 04351P101 |
| — | AKERO THERAPEUTICS INC | 403,787 | $5.73M | 0.4% | $22.77 | — | COM | 00973Y108 |
| KROS | KEROS THERAPEUTICS INC | 100,000 | $5.438M | 0.4% | $49.87 | +2.9% | COM | 492327101 |
| BEAM | BEAM THERAPEUTICS INC | 90,045 | $5.16M | 0.4% | $73.61 | -10.9% | COM | 07373V105 |
| ELDN | ELEDON PHARMACEUTICALS INC | 1,305,095 | $5.142M | 0.4% | $15.09 | -74.3% | COM | 28617K101 |
| — | ELEVATION ONCOLOGY INC | 1,983,165 | $4.998M | 0.4% | $12.89 | — | COM | 28623U101 |
| — | VIGIL NEUROSCIENCE INC | 616,786 | $4.206M | 0.3% | $6.82 | — | COM | 92673K108 |
| — | MIRATI THERAPEUTICS INC | 50,000 | $4.111M | 0.3% | $66.72 | — | COM | 60468T105 |
| PLRX | PLIANT THERAPEUTICS INC | 482,413 | $3.382M | 0.3% | $26.54 | -61.5% | COM | 729139105 |
| — | ITEOS THERAPEUTICS INC | 100,000 | $3.218M | 0.2% | $24.67 | — | COM | 46565G104 |
| — | ICOSAVAX INC | 426,393 | $3.002M | 0.2% | $28.70 | — | COM | 45114M109 |
| GLSHQ | GELESIS HLDGS INC | 626,108 | $2.751M | 0.2% | $4.31 | 0.0% | COM | 36850R204 |
| PYXS | PYXIS ONCOLOGY INC | 668,854 | $2.702M | 0.2% | $11.45 | -36.2% | COMMON STOCK | 747324101 |
| — | HARPOON THERAPEUTICS INC | 540,600 | $2.687M | 0.2% | $9.47 | — | COM | 41358P106 |
| — | ATRECA INC | 800,000 | $2.536M | 0.2% | $8.53 | — | CL A COM | 04965G109 |
| CABA | CABALETTA BIO INC | 1,154,424 | $2.343M | 0.2% | $11.85 | -77.9% | COM | 12674W109 |
| — | GALECTO INC | 1,020,238 | $2.245M | 0.2% | $12.30 | — | COM | 36322Q107 |
| — | RENOVACOR INC | 500,000 | $2.12M | 0.2% | $9.05 | — | COM | 75989E106 |
| MGTX | MEIRAGTX HLDGS PLC | 150,000 | $2.078M | 0.2% | $19.14 | -19.5% | COM | G59665102 |
| — | ASTRIA THERAPEUTICS INC | 300,000 | $2.013M | 0.2% | $8.84 | — | COM | 04635X102 |
| — | AKOUOS INC | 394,500 | $1.874M | 0.1% | $21.34 | — | COM | 00973J101 |
| — | Y-MABS THERAPEUTICS INC | 150,000 | $1.782M | 0.1% | $31.28 | — | COM | 984241109 |
| GOSS | GOSSAMER BIO INC | 198,382 | $1.722M | 0.1% | $12.02 | -19.8% | COM | 38341P102 |
| AUTL | AUTOLUS THERAPEUTICS PLC | 392,167 | $1.635M | 0.1% | $31.47 | — | SPON ADS | 05280R100 |
| — | CHEMOMAB THERAPEUTICS LTD | 288,168 | $1.383M | 0.1% | $4.80 | — | SPONSORED ADS | 16385C104 |
| ANAB | ANAPTYSBIO INC | 50,000 | $1.237M | 0.1% | $23.10 | +31.0% | COM | 032724106 |
| — | PRECISION BIOSCIENCES INC | 346,524 | $1.067M | 0.1% | $17.95 | — | COM | 74019P108 |
| — | GRAPHITE BIO INC | 203,153 | $1.036M | 0.1% | $29.19 | — | COM | 38870X104 |
| — | IMV INC | 234,374 | $337K | 0.0% | $3.05 | — | COM | 44974L103 |
| — | ORCHARD THERAPEUTICS PLC | 256,649 | $183K | 0.0% | $16.35 | — | ADS | 68570P101 |
| — | X4 PHARMACEUTICALS INC | 103,980 | $182K | 0.0% | $6.43 | — | COM | 98420X103 |